At UBS, Instrument Vendors Acknowledge Pharma Spending Growth May Not Return to Previous Highs | GenomeWeb
Officials from several instrument vendors that are part of the BCW Index acknowledged at an investors’ conference this week that they do not expect pharma spending growth to return to the relatively high levels of a few years ago, though most agree that the spending environment has improved recently.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.